Brief: Caribou Biosciences Received Notice From AbbVie Manufacturing Management Unlimited That Abbvie Elected To Terminate Collaboration, License Agreement

Caribou Biosciences

26/09/2023 23:25

Sept 26 (Reuters) - Caribou Biosciences Inc  CRBU.O :
    * CARIBOU BIOSCIENCES- RECEIVED NOTICE FROM ABBVIE
MANUFACTURING
MANAGEMENT UNLIMITED THAT ABBVIE ELECTED TO TERMINATE
COLLABORATION, LICENSE AGREEMENT
    * CARIBOU BIOSCIENCES INC-  TERMINATION OF COLLABORATION AND
LICENSE AGREEMENT, AS AMENDED, BY AND BETWEEN COMPANY AND
ABBVIE, DATED FEBRUARY 9, 2021
    * CARIBOU BIOSCIENCES INC- BY MUTUAL AGREEMENT OF COMPANY
AND
ABBVIE, TERMINATION OF AGREEMENT WILL BE EFFECTIVE OCTOBER 25,
2023
    * CARIBOU BIOSCIENCES INC- UNDER TERMS OF AGREEMENT, CO WAS
CONDUCTING PRECLINICAL RESEARCH, MANUFACTURING ACTIVITIES FOR
TWO ABBVIE PROGRAMS
    * CARIBOU BIOSCIENCES INC- ABBVIE HAS ELECTED NOT TO ADVANCE
THE
TWO PROGRAMS UNDER AGREEMENT

Further company coverage:  CRBU.O 

 ((Reuters.briefs@thomsonreuters.com;))